Heart disease in the Netherlands: a quantitative update
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vaartjes I, Koopman C, van Dis I, et al. Hart- en vaatziekten in Nederland 2013, cijfers over leefstijl, risicofactoren, ziekte en sterfte. The Hague: Dutch Heart Foundation; 2013.
National Institute for Public Health and the Environment (RIVM). National Public Health Compass. 2013 [November 19, 2013]; Available from: http://www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/hartvaatstelsel/
Ives DG, Samuel P, Psaty BM, et al. Agreement between nosologist and cardiovascular health study review of deaths: implications of coding differences. J Am Geriatr Soc. 2009;57:133–9.
Kelson M, Farebrother M. The effect of inaccuracies in death certification and coding practices in the European Economic Community (EEC) on international cancer mortality statistics. Int J Epidemiol. 1987;16:411–4.
van der Meer JTM, Thompson J, Valkenburg HA, et al. Epidemiology of bacterial endocarditis in the Netherlands. I. Patient characteristics. Arch Intern Med. 1992;152:1863–8.
Engelfriet PM, Hoogenveen RT, Boshuizen HC, et al. To die with or from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics? Eur J Heart Fail. 2011;13:377–83.
Straus SMJM, Bleumink GS, Dieleman JP, et al. The incidence of sudden cardiac death in the general population. J Clin Epidemiol. 2004;57:98–102.
Straus SMJM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362–7.
Koopman C, Bots ML, van Oeffelen AAM, et al. Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007. Int J Cardiol. 2013;168:993–8.
Koopman C, van Dis I, Visseren FLJ, et al. Hart- en vaatziekten in Nederland 2012, cijfers over risicofactoren, ziekte en sterfte. The Hague: Dutch Heart Foundation; 2012.
Board of the Netherlands Association for Cardio-Thoracic Surgery. De Nederlandse dataregistratie hartchirurgie: resultaten van samenwerking tussen 16 Nederlandse hartchirurgische centra. Utrecht: Netherlands Association for Cardio-Thoracic Surgery (NVT); 2012 [November 19, 2013]; Available from: http://www.nvtnet.nl/index.asp?news_id=113&category_id=0
Vaartjes I, van Dis I, Visseren FLJ, et al. Hart- en vaatziekten in Nederland 2011, cijfers over leefstijl- en risicofactoren, ziekte en sterfte. The Hague: Dutch Heart Foundation; 2011.
Siregar S. Safety in cardiac surgery [PhD thesis, Utrecht University, Utrecht, the Netherlands]. Enschede: Gildeprint Drukkerijen; 2013 [November 19, 2013]; Available from: http://igitur-archive.library.uu.nl/dissertations/2013-0612-200800/UUindex.html
Siregar S, Groenwold RHH, Versteegh MIM, et al. Data resource profile: adult cardiac surgery database of the Netherlands association for cardio-thoracic surgery. Int J Epidemiol. 2013;42:142–9.
de Winter RJ. Percutaneous coronary intervention without surgery on-site is here to stay. Neth Heart J. 2013;21:446–8.
Bleumink GS, Knetsch AM, Sturkenboom MCJM, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam study. Eur Heart J. 2004;25:1614–9.
Bonneux L, Barendregt JJ, Meeter K, et al. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health. 1994;84:20–8.
Engelfriet PM, Hoogenveen RT, Poos MJJC, et al. Hartfalen: epidemiologie, risicofactoren en toekomst. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2012 [November 19, 2013]; Available from: http://www.rivm.nl/bibliotheek/rapporten/260401006.html
Dharmarajan K, Hsieh AF, Lin Z, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309:355–63.
Stewart S, MacIntyre K, Hole DJ, et al. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001;3:315–22.
Heeringa J, van der Kuip DAM, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–53.
Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746–51.
Soedamah-Muthu SS, Geleijnse JM, Giltay EJ, et al. Levels and trends in cardiovascular risk factors and drug treatment in 4837 elderly Dutch myocardial infarction patients between 2002 and 2006. Neth Heart J. 2012;20:102–9.
van Dis I, Geleijnse JM, Verschuren WMM. Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach. Neth Heart J. 2012;20:320–5.
World Health Organization. The European health report 2012: charting the way to well-being. Copenhagen: World Health Organization; 2013 [November 19, 2013]; Available from: http://www.euro.who.int/en/data-and-evidence/european-health-report-2012